ArticleDiagnostics (Basel, Switzerland)2022
EDLDR: An Ensemble Deep Learning Technique for Detection and Classification of Diabetic Retinopathy.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 106 citations in OpenAlex.
- RDE-DR: robust deep ensemble CNNs for automated diabetic retinopathy detection from fundus images.Scientific reports · 2026Article
- An enhanced diabetic retinopathy detection approach using optimized deep learning technique.Scientific reports · 2026Article
- Advancing Visual Perception Through VCANet-Crossover Osprey Algorithm: Integrating Visual Technologies.Journal of imaging informatics in medicine · 2026Article
- Predicting major organ complications in primary Sjögren's disease using a machine learning ensemble strategy: a dual-center retrospective clinical study.Frontiers in immunology · 2026Article
- Graph-enhanced deep learning for diabetic retinopathy diagnosis: A quality-aware and uncertainty-driven approach.PLoS computational biology · 2025Article
- Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease.International urology and nephrology · 2025Review
- Transformer attention fusion for fine grained medical image classification.Scientific reports · 2025Article
- Artificial intelligence for early detection of diabetes mellitus complications via retinal imaging.Journal of diabetes and metabolic disorders · 2025Review
- The role of artificial intelligence in the diagnosis of diabetic retinopathy through retinal lesion features: a narrative review.Quantitative imaging in medicine and surgery · 2025Review
- A multi model deep net with an explainable AI based framework for diabetic retinopathy segmentation and classification.Scientific reports · 2025Article
- A deep learning based model for diabetic retinopathy grading.Scientific reports · 2025Article
- Artificial intelligence in proliferative diabetic retinopathy: advancing diagnosis, precision surgery, and anti-VEGF therapy optimization.Frontiers in medicine · 2025Review
- Deep learning based binary classification of diabetic retinopathy images using transfer learning approach.Journal of diabetes and metabolic disorders · 2024Article
- Interpretable Detection of Diabetic Retinopathy, Retinal Vein Occlusion, Age-Related Macular Degeneration, and Other Fundus Conditions.Diagnostics (Basel, Switzerland) · 2024Article
- DR-NASNet: Automated System to Detect and Classify Diabetic Retinopathy Severity Using Improved Pretrained NASNet Model.Diagnostics (Basel, Switzerland) · 2023Article
- Level-set based adaptive-active contour segmentation technique with long short-term memory for diabetic retinopathy classification.Frontiers in bioengineering and biotechnology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is an ophthalmological disease that causes damage in the blood vessels of the eye. DR causes clotting, lesions or haemorrhage in the light-sensitive region of the retina. Person suffering from DR face loss of vision due to the formation of exudates or lesions in the retina. The detection of DR is critical to the successful treatment of patients suffering from DR. The retinal fundus images may be used for the detection of abnormalities leading to DR. In this paper, an automated ensemble deep learning model is proposed for the detection and classification of DR. The ensembling of a deep learning model enables better predictions and achieves better performance than any single contributing model. Two deep learning models, namely modified DenseNet101 and ResNeXt, are ensembled for the detection of diabetic retinopathy. The ResNeXt model is an improvement over the existing ResNet models. The model includes a shortcut from the previous block to next block, stacking layers and adapting split-transform-merge strategy. The model has a cardinality parameter that specifies the number of transformations. The DenseNet model gives better feature use efficiency as the dense blocks perform concatenation. The ensembling of these two models is performed using normalization over the classes followed by maximum a posteriori over the class outputs to compute the final class label. The experiments are conducted on two datasets APTOS19 and DIARETDB1. The classifications are carried out for both two classes and five classes. The images are pre-processed using CLAHE method for histogram equalization. The dataset has a high-class imbalance and the images of the non-proliferative type are very low, therefore, GAN-based augmentation technique is used for data augmentation. The results obtained from the proposed method are compared with other existing methods. The comparison shows that the proposed method has higher accuracy, precision and recall for both two classes and five classes. The proposed method has an accuracy of 86.08 for five classes and 96.98% for two classes. The precision and recall for two classes are 0.97. For five classes also, the precision and recall are high, i.e., 0.76 and 0.82, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.